Wanli Lu
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Biotechnology top 5%
- Microbial Metabolism and Applications
- Marine Sponges and Natural Products
Papers in
-
- RNA and protein synthesis mechanisms 4
- Genomics and Phylogenetic Studies 3
- Chemical Synthesis and Analysis 3
- Peroxisome Proliferator-Activated Receptors 2
- Pharmacology 10
- Microbial Natural Products and Biosynthesis 9
- Co-authors
- Taifo Mahmud (6 shared papers)Dongxin Lin (1 shared paper)Xiaoping Miao (1 shared paper)Kai‐Feng Pan (1 shared paper)Lian Zhang (1 shared paper)Wei‐Cheng You (1 shared paper)Niran Roongsawang (2 shared papers)Kevin A. Reynolds (4 shared papers)
- Journals
- Journal of the American Chemical Society (2 papers)Organic Letters (2 papers)ChemBioChem (2 papers)Scientific Reports (1 paper)Medicine (1 paper)
- Partner nations
- United StatesChinaGreece
In The Last Decade
Wanli Lu
21 papers receiving 851 citations
Peers
Comparison fields: 5 of 92
- Pharmacology 317
- Biotechnology 123
- Rheumatology 106
- Cancer Research 94
- Molecular Biology 413
Countries citing papers authored by Wanli Lu
This map shows the geographic impact of Wanli Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanli Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanli Lu more than expected).
Fields of papers citing papers by Wanli Lu
This network shows the impact of papers produced by Wanli Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanli Lu. The network helps show where Wanli Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanli Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 185 | |
| 2 | 2017 | 91 | |
| 3 | 2009 | 72 | |
| 4 | 2015 | 68 | |
| 5 | 2011 | 59 | |
| 6 | 2017 | 57 | |
| 7 | 2014 | 45 | |
| 8 | 2006 | 44 | |
| 9 | 2018 | 41 | |
| 10 | 2014 | 36 | |
| 11 | 2013 | 34 | |
| 12 | 2015 | 23 | |
| 13 | 2016 | 23 | |
| 14 | 1998 | 20 | |
| 15 | 2021 | 16 | |
| 16 | 2005 | 15 | |
| 17 | 2018 | 12 | |
| 18 | Egr1 deficiency disrupts dynamic equilibrium of chondrocyte extracellular matrix through PPARγ/RUNX2 signaling pathways. | 2018 | 9 |
| 19 | 2018 | 5 | |
| 20 | 2017 | 5 |
About Wanli Lu
Wanli Lu is a scholar working on Molecular Biology, Pharmacology, Biotechnology, Oncology and Rheumatology, having authored 21 papers that have together received 862 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (9 papers), Microbial Metabolism and Applications (4 papers), RNA and protein synthesis mechanisms (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Genomics and Phylogenetic Studies (3 papers), Chemical Synthesis and Analysis (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Marine Sponges and Natural Products (2 papers). The work is most often cited by research in Pharmacology (317 citations), Biotechnology (123 citations), Rheumatology (106 citations), Cancer Research (94 citations) and Molecular Biology (413 citations). Wanli Lu has collaborated with scholars based in United States, China and Greece. Frequent co-authors include Taifo Mahmud, Dongxin Lin, Xiaoping Miao, Kai‐Feng Pan, Lian Zhang, Wei‐Cheng You, Niran Roongsawang, Kevin A. Reynolds, Papireddy Kancharla and Jane X. Kelly. Their work appears in journals such as Journal of the American Chemical Society, Organic Letters, ChemBioChem, Scientific Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.